JAK2V617F mutation only in vascular cells did not induce myeloproliferative neoplasm (Supplementary Fig. 4B) and did not induce elastin degradation (Supplementary Fig. 4D) or aortic dilation (Supplementary Fig. 4C). This evidence concerns the gene ELN and myeloproliferative disorder.